Sarah Paulin
- Molecular Medicine top 2%
- Molecular Biology
- Applied Microbiology and Biotechnology top 1%
- Pharmacology top 10%
- Infectious Diseases
- Co-authors
- Peter BeyerMelvin SpigelmanLynn L. SilverChristian LienhardtMark S. ButlerMical PaulJohn RexLloyd G. Czaplewski
- Topics
- Antibiotic Use and Resistance (7 papers)Antibiotic Resistance in Bacteria (6 papers)Health Systems, Economic Evaluations, Quality of Life (2 papers)
- Partner nations
- SwitzerlandUnited KingdomUnited States
In The Last Decade
Sarah Paulin
10 papers receiving 625 citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Molecular Medicine 221
- Molecular Biology 212
- Applied Microbiology and Biotechnology 166
- Pharmacology 99
- Infectious Diseases 94
Countries citing papers authored by Sarah Paulin
This map shows the geographic impact of Sarah Paulin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Paulin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Paulin more than expected).
Fields of papers citing papers by Sarah Paulin
This network shows the impact of papers produced by Sarah Paulin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Paulin. The network helps show where Sarah Paulin may publish in the future.
Co-authorship network of co-authors of Sarah Paulin
This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Paulin. A scholar is included among the top collaborators of Sarah Paulin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Paulin. Sarah Paulin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed.breakdown → | 167 |
| 3 | 20 | |
| 4 | 43 | |
| 5 | 10 | |
| 6 | 65 | |
| 7 | 159 | |
| 8 | 18 | |
| 9 | 72 | |
| 10 | 52 | |
| 11 | 26 |
About Sarah Paulin
Sarah Paulin is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Geriatrics and Gerontology, having authored 11 papers that have together received 632 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (7 papers), Antibiotic Resistance in Bacteria (6 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (166 citations), Molecular Medicine (221 citations) and Microbiology (80 citations). Sarah Paulin has collaborated with scholars based in Switzerland, United Kingdom and United States. Frequent co-authors include Peter Beyer, Melvin Spigelman, Lynn L. Silver, Christian Lienhardt, Mark S. Butler, Mical Paul, John Rex, Lloyd G. Czaplewski, Guy Thwaites and Lorenzo Moja. Their work appears in journals such as The Lancet, PLoS ONE and The Lancet Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.